Related references
Note: Only part of the references are listed.Serum YKL-40 as a marker for cervical adenocarcinoma
A. Mitsuhashi et al.
ANNALS OF ONCOLOGY (2009)
Alteration of DBP Levels in CSF of Patients with MS by Proteomics Analysis
Zhaoyu Qin et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2009)
Plasma chitotriosidase activity in multiple sclerosis
M. Comabella et al.
CLINICAL IMMUNOLOGY (2009)
CSF proteome analysis in clinically isolated syndrome (CIS): Candidate markers for conversion to definite multiple sclerosis
H. Tumani et al.
NEUROSCIENCE LETTERS (2009)
Disability and T2 MRI lesions:: a 20-year follow-up of patients with relapse onset of multiple sclerosis
L. K. Fisniku et al.
BRAIN (2008)
CSF proteome analysis in multiple sclerosis patients by two-dimensional electrophoresis
D. Chiasserini et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
Serum YKL-40 as a marker of disease activity and stricture formation in patients with Crohn's disease
Yusuf Erzin et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Differential cerebro spinal fluid proteome investigation of Leber hereditary optic neuropathy (LHON) and multiple sclerosis
Simona D'Aguanno et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Multiple sclerosis-related proteins identified in cerebrospinal fluid by advanced mass spectrometry
Marcel P. Stoop et al.
PROTEOMICS (2008)
Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia
Mine Kucur et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2008)
Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?
M. Tintore et al.
NEUROLOGY (2008)
Cerebrospinal fluid proteome profile in multiple sclerosis
V. Lehmensiek et al.
MULTIPLE SCLEROSIS (2007)
Precise protein quantification based on peptide quantification using iTRAQ™
Andreas M. Boehm et al.
BMC BIOINFORMATICS (2007)
Fibronectin- and vitronectin-induced microglial activation and matrix metalloproteinase-9 expression is mediated by integrins α5β1 and αvβ5
Richard Milner et al.
JOURNAL OF IMMUNOLOGY (2007)
Protein labeling by iTRAQ: A new tool for quantitative mass spectrometry in proteome research
Sebastian Wiese et al.
PROTEOMICS (2007)
Preoperative serum YK-L-40 is a marker for detection and prognosis of endometrial cancer
Catherine S. M. Diefenbach et al.
GYNECOLOGIC ONCOLOGY (2007)
Lack of association between antimyelin antibodies and progression to multiple sclerosis
Jens Kuhle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Antimyelin antibodies with no progression to multiple sclerosis
Raul Pelayo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Intrathecal chitotriosidase and the outcome of multiple sclerosis
S. Sotgiu et al.
MULTIPLE SCLEROSIS JOURNAL (2006)
Baseline MRI predicts future attacks and disability in clinically isolated syndromes
M. Tintore et al.
NEUROLOGY (2006)
Lumbar cerebrospinal fluid proteome in multiple sclerosis: Characterization by ultrafiltration, liquid chromatography, and mass spectrometry
Jean-Paul Noben et al.
JOURNAL OF PROTEOME RESEARCH (2006)
A perspective on the use of iTRAQ™ reagent technology for protein complex and profiling studies
LR Zieske
JOURNAL OF EXPERIMENTAL BOTANY (2006)
Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel- or LC-MALDI TOF/TOF
WW Wu et al.
JOURNAL OF PROTEOME RESEARCH (2006)
Cleavage of cystatin C in the cerebrospinal fluid of patients with multiple sclerosis
DN Irani et al.
ANNALS OF NEUROLOGY (2006)
Inflammatory cytokines induce production of CHI3L1 by articular chondrocytes
AD Recklies et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Increased serum YKL-40 in patients with pulmonary sarcoidosis - a potential marker of disease activity?
JS Johansen et al.
RESPIRATORY MEDICINE (2005)
Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and clCAT with multidimensional liquid chromatography and tandem mass spectrometry
L DeSouza et al.
JOURNAL OF PROTEOME RESEARCH (2005)
The impact of blood contamination on the proteome of cerebrospinal fluid
JS You et al.
PROTEOMICS (2005)
Kappa free light chains in cerebrospinal fluid as markers of intrathecal immunoglobulin synthesis
C Fischer et al.
CLINICAL CHEMISTRY (2004)
Functional regulatory immune responses against human cartilage glycoprotein-39 in health vs. proinflammatory responses in rheumatoid arthritis
JHM van Bilsen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
High serum YKL-40 level in patients with small cell lung cancer is related to early death
JS Johansen et al.
LUNG CANCER (2004)
Apolipoprotein A-I infiltration in rheumatoid arthritis synovial tissue: a control mechanism of cytokine production?
B Bresnihan et al.
ARTHRITIS RESEARCH & THERAPY (2004)
Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients
D Dumont et al.
PROTEOMICS (2004)
Semaphorin 7A promotes axon outgrowth through integrins and MAPKs
RJ Pasterkamp et al.
NATURE (2003)
Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event
T Berger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Impaired fibrinolysis in multiple sclerosis: a role for tissue plasminogen activator inhibitors
D Gveric et al.
BRAIN (2003)
Improved resolution of human cerebrospinal fluid proteins on two-dimensional gels
BN Hammack et al.
MULTIPLE SCLEROSIS (2003)
No association of vitamin D-binding protein gene polymorphisms in Japanese patients with MS
M Niino et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
A longitudinal study of abnormalities on MRI and disability from multiple sclerosis
PA Brex et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
Raised human cartilage glycoprotein-39 plasma levels in patients with rheumatoid arthritis and other inflammatory conditions
K Vos et al.
ANNALS OF THE RHEUMATIC DISEASES (2000)
Share Paper
